GNH USA

Europe — EMA

Nefrosol Cu Potasiu

GNH USA supplies Nefrosol Cu Potasiu (Electrolyte solution), a IV electrolyte replacement for dehydration, renal support and post‑operative fluid management.

Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc

Request sourcing

1
Pack/s

What is Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?

Sodium Hydrogen Carbonate, the active ingredient in Nefrosol Cu Potasiu, is an excipient solvent (IV electrolyte solution) presented as a solution for injection for intravenous use. It helps replace lost electrolytes and maintain acid‑base balance in patients requiring fluid therapy.

GNH USA supplies Nefrosol Cu Potasiu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

What is Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc used for?

Nefrosol Cu Potasiu is an intravenous electrolyte solution used to correct fluid and electrolyte disturbances in several clinical settings. - Dehydration: restores sodium, potassium, magnesium, calcium and bicarbonate levels to support hydration and cellular function. - Acute renal failure: provides essential electrolytes to aid renal recovery and prevent metabolic derangements. - Post‑operative care: maintains electrolyte balance and acid‑base status during peri‑operative fluid management.

What are the side effects of Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?

Nefrosol Cu Potasiu may be associated with the following adverse reactions.

Common Side Effects: - Injection site pain or irritation. - Transient hypernatremia. - Transient hyperkalemia. - Mild nausea. - Temporary electrolyte imbalance.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Anaphylactic or severe hypersensitivity reaction. - Fluid overload causing pulmonary edema. - Severe metabolic alkalosis. - Severe hypotension due to rapid infusion.

What precautions apply to Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc?

Before administering Nefrosol Cu Potasiu, consider these safety measures. - Assess baseline electrolyte levels: verify serum sodium, potassium, magnesium, calcium and bicarbonate. - Monitor cardiac rhythm: especially in patients with cardiac disease or electrolyte abnormalities. - Adjust infusion rate in renal impairment: slower rates reduce risk of electrolyte overload. - Avoid in patients with known hypersensitivity to any component of the solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc interact with?

Nefrosol Cu Potasiu can interact with other medications that affect electrolyte balance or cardiovascular function.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of dangerous hyperkalemia. - Intravenous calcium channel blockers: additive cardiovascular effects. - High‑dose sodium bicarbonate with other alkalinizing agents: potential metabolic alkalosis.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase electrolyte loss, requiring closer monitoring. - ACE inhibitors or ARBs: monitor potassium levels. - Blood transfusions: watch calcium concentrations during massive transfusion protocols.

Frequently asked questions

What is Nefrosol Cu Potasiu used for?+
Nefrosol Cu Potasiu is an intravenous electrolyte solution used to replenish essential ions such as sodium, potassium, magnesium, calcium and bicarbonate. It is indicated for patients with dehydration, acute renal failure, or those requiring electrolyte management during post‑operative care and other clinical situations where fluid and electrolyte balance must be restored.
How does the active ingredient in Nefrosol Cu Potasiu work?+
The active ingredients provide a balanced mix of electrolytes that directly enter the bloodstream when infused. These ions help re‑establish normal extracellular fluid volume, correct osmotic imbalances, support nerve and muscle function, and maintain acid‑base homeostasis through bicarbonate buffering, thereby addressing the physiological deficits caused by fluid loss.
What is the usual dose of Nefrosol Cu Potasiu?+
The dose of Nefrosol Cu Potasiu is individualized by the prescribing clinician based on the patient’s electrolyte status, fluid requirements, weight, renal function and the clinical scenario. Healthcare professionals calculate the appropriate volume and rate of infusion to safely correct the identified deficits.
Is Nefrosol Cu Potasiu safe during pregnancy or breastfeeding?+
Safety data for Nefrosol Cu Potasiu in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it must be prescribed and monitored by a qualified healthcare provider.
How do I order Nefrosol Cu Potasiu from GNH USA?+
To order Nefrosol Cu Potasiu, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Nefrosol Cu Potasiu compare with other electrolyte solutions?+
Nefrosol Cu Potasiu offers a comprehensive electrolyte profile that includes sodium, potassium, magnesium, calcium and bicarbonate, making it suitable for a broad range of fluid‑replacement needs. Compared with simpler saline solutions, it provides additional ions that help correct more complex electrolyte disturbances without the need for multiple separate infusions.
What are the storage and handling requirements for Nefrosol Cu Potasiu?+
The product must be stored at 2‑8 °C, kept refrigerated, protected from light, and should never be frozen or shaken. Before use, inspect the container for any signs of contamination or damage, and allow the solution to reach room temperature if required by the administration protocol.
How is Nefrosol Cu Potasiu administered?+
Nefrosol Cu Potasiu is administered intravenously as a sterile solution for injection. The infusion rate is determined by the prescribing clinician, taking into account the patient’s electrolyte deficits, cardiac status and renal function. Administration should be performed by qualified healthcare personnel in a setting equipped for IV therapy monitoring.
What are the most serious risks associated with Nefrosol Cu Potasiu?+
Serious risks include severe hyperkalemia, which can cause life‑threatening cardiac arrhythmias, anaphylactic reactions, fluid overload leading to pulmonary edema, and profound metabolic alkalosis. Continuous monitoring of electrolyte levels, cardiac rhythm and fluid balance is essential to mitigate these risks.
Who should not use Nefrosol Cu Potasiu?+
Patients with known hypersensitivity to any component of the solution, those with uncontrolled hyperkalemia, severe renal failure not managed with dialysis, or individuals at high risk for fluid overload should not receive Nefrosol Cu Potasiu unless a clinician determines that benefits outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc
Route
Intravenous Use
Manufacturer
B.Braun Avitum Ag
Origin
EU